- Approval Id
- 092ac10f6fe1fe86
- Drug Name
- STUGERON TABLET 25 mg
- Product Name
- STUGERON TABLET 25 mg
- Approval Number
- SIN01122P
- Approval Date
- 1988-05-13
- Registrant
- JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
- Licence Holder
- JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Pharmacy Only
- Dosage Form
- TABLET
- Dosage
- **Dosage and Administration**
**Dosage**
**_Disorders of balance – Adults_**
25 mg tablet: 1 tablet three times a day.
**_Prophylaxis of motion sickness:_**
Adults and adolescents aged 13 years and above
- 25 mg tablet: 1 tablet at least half an hour before travelling; to be repeated every 6 hours.
Children aged 6 to 12 years:
- Half of the adult dose is recommended.
**Administration**
STUGERON® should preferably be taken orally after meals.
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
- Disorders of balance – maintenance therapy for symptoms of labyrinthine disorders, including vertigo, dizziness, tinnitus, nystagmus, nausea and vomiting.
- Prophylaxis of motion sickness.
- Contraindications
- **Contraindications**
STUGERON® is contraindicated in patients with known hypersensitivity to the drug.
- Atc Code
- N07CA02
- Atc Item Name
- cinnarizine
- Pharma Manufacturer Name
- JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD.
- Company Detail Path
- /organization/johnson-and-johnson-international-singapore-pte-ltd
